Cargando…
Circulating miR-221/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case–control study
The high mortality rate in breast cancer (BC) patients is generally due to metastases resistant to systemic therapy. Two causes of systemic therapy resistance in BC patients are circulating miRNAs-221 and miR-222, leading to improved BC cell proliferation, survival, and reduced cell apoptosis. This...
Autores principales: | Patellongi, Ilhamjaya, Amiruddin, Alfiah, Massi, Muhammad N., Islam, Andi A., Pratama, Muhammad Y., Sutandyo, Noorwati, Latar, Nani H.M., Faruk, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406100/ https://www.ncbi.nlm.nih.gov/pubmed/37554919 http://dx.doi.org/10.1097/MS9.0000000000001061 |
Ejemplares similares
-
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
por: Amiruddin, Alfiah, et al.
Publicado: (2021) -
The role of microRNA in cancer cachexia and muscle wasting: A review article
por: Sutandyo, Noorwati
Publicado: (2021) -
Metformin improves FOXP3 mRNA expression through suppression of interferon gamma levels in pristane-induced murine models of lupus
por: Sumantri, Stevent, et al.
Publicado: (2021) -
Karnofsky Performance Scale and Neurological Assessment of Neuro-Oncology Scale as Early Predictor in Glioma
por: Gunawan, Pricilla Yani, et al.
Publicado: (2020) -
Role of MicroRNAs-221/222 in Digestive Systems
por: Matsuzaki, Juntaro, et al.
Publicado: (2015)